# TALC

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid5032109
Categories: industrial, pharma
Functions: Abrasive, Absorbent, Anti-adhesive/cohesive, Anti-caking agent, Deodorizer, Filler, Humectant, Mineral, Opacifer, Pigment, Processing aids not otherwise specified, Volumizing Agent
Identifier: DTXSID5032109

> TALC is used as abrasive / absorbent. EPA CPDat observed this chemical in 13323 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings. Assessed from 42 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 13323 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 13323 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings. EPA CPDat classifies this chemical for functional uses including Abrasive, Absorbent, Volumizing Agent.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Potency: NA
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 15 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 729 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 87 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 14 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 420 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 5119 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: 4.5 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 322 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Maximum daily exposure: 525 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 296 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 50 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 69 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 735 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 234 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 46 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 1000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 202 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 320.75 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 349 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 56 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 91 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 80 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 357 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
- US: inactive ingredient database — Route: RECTAL; Dosage form: TABLET; Potency: 32.4 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 32.4 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: POWDER; Maximum daily exposure: 9235 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 4 active drug products and 4 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: 74.6 %w/w
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._